Melanoma Journal Articles for August 2019

Dermatology Online Journal

Melanoma screening using patient self-assessed risk and total body photography

2019

Drugge, Elizabeth D, Okundaye, Osatohamwen I, Sarac, Rebecca M, Drugge, Rhett J

https://escholarship.org/uc/item/33h4r9bk

Dermatology Online Journal

Melanoma screening using patient self-assessed risk and total body photography

2019

Drugge, Elizabeth D, Okundaye, Osatohamwen I, Sarac, Rebecca M, Drugge, Rhett J

https://escholarship.org/uc/item/33h4r9bk

British Journal of Dermatology

Development and external validation study of a melanoma risk prediction model incorporating clinically?assessed naevi and solar lentigines

Vuong, B.K. Armstron, M. Drummond, J.L. Hopper, J.H. Barrett, J.R. Davies, D.T. Bishop, J. Newton?Bishop, J.F. Aitken, G.G. Giles, H. Schmid, M.A. Jenkins, G.J. Mann, K. McGeechan, A.E. Cust

First published: 04 August 2019

https://doi.org/10.1111/bjd.18411

JAMA Network Open

Original Investigation

Cardiology

August 9, 2019

Cardiovascular Adverse Events Associated With BRAF and MEK InhibitorsA Systematic Review and Meta-analysis

Raluca I. Mincu, PhD¹; Amir A. Mahabadi, MD¹; Lars Michel, MD¹; et alSimone M. Mrotzek, MD¹; Dirk Schadendorf, MD²; Tienush Rassaf, MD¹; Matthias Totzeck, MD¹

JAMA Netw Open. 2019;2(8):e198890. doi:10.1001/jamanetworkopen.2019.8890

JNCI Cancer Spectr. 2019 Jan 9;2(4):pky068. doi: 10.1093/jncics/pky068. eCollection 2018 Oct.

Familial Risks and Mortality in Second Primary Cancers in Melanoma.

Chattopadhyay S¹, Hemminki A^2,3, Försti A^1,3, Sundquist K^3,4,5, Sundquist J^6,4,5, Hemminki K⁶.

Dove Press

Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12

Authors Wei X, Gu X, Ma M, Lou C

Received 23 November 2018

Accepted for publication 1 March 2019

Published 12 August 2019 Volume 2019:12 Pages 6323—6335

DOI https://doi.org/10.2147/OTT.S195796

Journal of Immunotherapy

Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors

Afzal, Muhammad Z.^*; Sarwar, Tayyaba^†; Shirai, Keisuke^‡

Journal of Immunotherapy: September 2019 – Volume 42 – Issue 7 – p 251–264

doi: 10.1097/CJI.0000000000000272

Clinical Studies

Dove Press

Typical electronegative electroretinography and nyctalopia as a presenting feature of systemic malignant melanoma

Authors Vercio A, Chalam KV, Winter T

Received 14 January 2019

Accepted for publication 9 July 2019

Published 13 August 2019 Volume 2019:12 Pages 265—276

DOI https://doi.org/10.2147/IMCRJ.S201500

International Journal of Cancer

Cancer Epidemiology

Full Access

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

First published: 22 January 2019 https://doi.org/10.1002/ijc.32150

The Lancet

ARTICLES| VOLUME 394, ISSUE 10197, P471-477, AUGUST 10, 2019

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Deborah Utjés, MD, Jonas Malmstedt, MD, Jüri Teras, MD, Prof Krzysztof Drzewiecki, MD, Hans Petter Gullestad, MD, Prof Christian Ingvar, MD, et al.

Published:July 04, 2019DOI:https://doi.org/10.1016/S0140-6736(19)31132-8

REVIEW

Open Access

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta?analysis and systematic review

Qingliang Yu, Jiayi Xie, Jiangmiao Li, Yunxin Lu, Liang Liao

First published: 08 August 2019 https://doi.org/10.1002/cam4.2248

Cancer

Original Article Full Access

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD?1 in patients with metastatic melanoma

Gustavo Schvartsman MD, Junsheng Ma PhD, Roland L. Bassett Jr MS, Lauren E. Haydu PhD, Rodabe Navroze Amaria MD, Patrick Hwu MD, Michael K. Wong MD, PhD, et., al.

First published: 09 August 2019 https://doi.org/10.1002/cncr.32454

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Serigne N. Lo,
Angela M. Hong,
Lauren E. Haydu,
Tasnia Ahmed,
Elizabeth J. Paton,
Victoria Steel,
George Hruby,
Anh Tran,
Rachael L. Morton,
Anna K. Nowak,
Janette L. Vardy,
Katharine J. Drummond,
Haryana M. Dhillon,
Catherine Mandel,
Richard A. Scolyer,
Mark R. Middleton,
Bryan H. Burmeister,
John F. Thompson&
Gerald B. Fogarty

Trialsvolume 20, Article number: 477 (2019)

Translational Oncology

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms?

HusseinAkil*¹ JacquesRouanet*^†‡1 ClaireViallard*SophieBesse*PhilippeAuzeloux*Jean-MichelChezal*ElisabethMiot-Noirault*MercedesQuintana*FrançoiseDegoul^a

https://doi.org/10.1016/j.tranon.2019.07.015

British Journal of Dermatology

Genetic Alterations in Primary Melanoma in Taiwan

Y.?S. Sheen, K.?T. Tan, K.?P. Tse, Y.?H. Liao, M.?H. Lin, J.?S. Chen, J.?Y. Liau, Y.?J. Tseng, C.?H. Lee, C.?H. Hong, J.?B. Liao, H.?T. Chang, C.?Y. Chu

First published: 13 August 2019 https://doi.org/10.1111/bjd.18425

JAMA Dermatology

Original Investigation

May 15, 2019

Patients’ Views About Skin Self-examination After Treatment for Localized Melanoma

Mbathio Dieng, PhD^1,2; Amelia K. Smit, MPH^2,3; Jolyn Hersch, PhD⁴; et alRachael L. Morton, PhD^1,2; Anne E. Cust, PhD^2,3; Les Irwig, PhD⁴; Donald Low⁵; Cynthia Low, MLitt⁵; Katy J. L. Bell, PhD⁴

Author Affiliations Article Information

JAMA Dermatol. 2019;155(8):914-921. doi:10.1001/jamadermatol.2019.0434

New England Journal of Medicine

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Caroline Robert, M.D., Ph.D., Jean J. Grob, M.D., Ph.D., Daniil Stroyakovskiy, M.D., Boguslawa Karaszewska, M.D., Axel Hauschild, M.D., Evgeny Levchenko, M.D., Vanna Chiarion Sileni, M.D., Jacob Schachter, M.D., Claus Garbe, M.D., Igor Bondarenko, M.D., Ph.D., Helen Gogas, M.D., Mario Mandalá, M.D., et al.

August 15, 2019
N Engl J Med 2019; 381:626-636 DOI: 10.1056/NEJMoa1904059

Original Article

No association between smoking and sentinel lymph node metastasis and survival in cutaneous melanoma

Tejera?Vaquerizo, M.A. Descalzo?Gallego, V. Traves, C. Requena, I. Bolumar, A. Pla, E. Nagore

First published: 08 July 2019 https://doi.org/10.1111/jdv.15789

BMC Cancer Cell International

NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression

Fei Ding, Jindong Lai, Yang Gao, Genhui Wang, Jingwen Shang, Daojun Zhang & Shumao Zheng

Cancer Cell International volume19, Article number: 217 (2019)
Published: 22 August 2019

JAMA Dermatology

Original Investigation

August 28, 2019

Evolution of Excisional Surgery Practices for Melanoma in the United States

Michael P. Lee, BS¹; Joseph F. Sobanko, MD²; Thuzar M. Shin, MD, PhD²; et alNicole M. Howe, MD²; John S. Barbieri, MD²; Christopher J. Miller, MD²; Jeremy R. Etzkorn, MD²

Author Affiliations

JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2346

JAMA Dermatology

Viewpoint

August 28, 2019

Mohs Micrographic Surgery for MelanomaAs Use Increases, So Does the Need for Best Practices

Christopher J. Miller, MD¹; Cerrene N. Giordano, MD²; H. William Higgins II, MD, MBE³

Author Affiliations

JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2589

Cancer Immunology Research

STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity

Rana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N Barber and James J Mulé

Published Online First August 28, 2019 DOI: 10.1158/2326-6066.CIR-19-0229

BioRxiv

Targeting effector pathways in RAC1^P29S-driven malignant melanoma

Cristina Uribe-Alvarez, Sandra Lucía Guerrero-Rodríguez, Jennifer Rhodes, Alexa Cannon, View ORCID ProfileJonathan Chernoff, Daniela Araiza-Olivera

doi: https://doi.org/10.1101/750489

Journal of Extracellular Vesicles

Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma

Su Chul Jang,Rossella Crescitelli,Aleksander Cvjetkovic,Valerio Belgrano,Roger Olofsson Bagge,Karin Sundfeldt,Takahiro Ochiya,Raghu Kalluri &Jan Lötvall show less

Article: 1635420 | Received 12 May 2018, Accepted 14 Jun 2019, Published online: 27 Aug 2019

https://doi.org/10.1080/20013078.2019.1635420

Melanoma Journal Articles for August 2019

Melanoma screening using patient self-assessed risk and total body photography

Melanoma screening using patient self-assessed risk and total body photography

Development and external validation study of a melanoma risk prediction model incorporating clinically?assessed naevi and solar lentigines

Cardiovascular Adverse Events Associated With BRAF and MEK InhibitorsA Systematic Review and Meta-analysis

Familial Risks and Mortality in Second Primary Cancers in Melanoma.

Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta?analysis and systematic review

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD?1 in patients with metastatic melanoma

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms?

British Journal of Dermatology

Genetic Alterations in Primary Melanoma in Taiwan

Patients’ Views About Skin Self-examination After Treatment for Localized Melanoma

Evolution of Excisional Surgery Practices for Melanoma in the United States

Mohs Micrographic Surgery for MelanomaAs Use Increases, So Does the Need for Best Practices

STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity

BioRxiv

Targeting effector pathways in RAC1^P29S-driven malignant melanoma

Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma

Our Partners

Melanoma Research Victoria

Quick Links

Melanoma Journal Articles for August 2019

Melanoma screening using patient self-assessed risk and total body photography

Melanoma screening using patient self-assessed risk and total body photography

Development and external validation study of a melanoma risk prediction model incorporating clinically?assessed naevi and solar lentigines

Cardiovascular Adverse Events Associated With BRAF and MEK InhibitorsA Systematic Review and Meta-analysis

Familial Risks and Mortality in Second Primary Cancers in Melanoma.

Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta?analysis and systematic review

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD?1 in patients with metastatic melanoma

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms?

British Journal of Dermatology

Genetic Alterations in Primary Melanoma in Taiwan

Patients’ Views About Skin Self-examination After Treatment for Localized Melanoma

Evolution of Excisional Surgery Practices for Melanoma in the United States

Mohs Micrographic Surgery for MelanomaAs Use Increases, So Does the Need for Best Practices

STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity

BioRxiv

Targeting effector pathways in RAC1P29S-driven malignant melanoma

Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma

Our Partners

Melanoma Research Victoria

Quick Links

Targeting effector pathways in RAC1^P29S-driven malignant melanoma